Zoetis (ZTS) Total Current Liabilities (2012 - 2026)
Zoetis' (ZTS) quarterly Total Current Liabilities came in at $2.1 billion in Q2 2026, down 38.77% year-over-year from $3.4 billion in Q2 2025, and little changed quarter-over-quarter from $2.1 billion in Q1 2026.
Analysis
Zoetis (ZTS) Total Current Liabilities (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Total Current Liabilities for 15 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 38.77% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 38.77% decrease from a year earlier, with the FY2025 full-year figure at $2.2 billion, down 36.31% from the prior year.
- Total Current Liabilities was $2.1 billion for Q2 2026 at Zoetis, roughly flat from $2.1 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $3.4 billion in Q4 2024 and troughed at $1.6 billion in Q3 2023.
- A 5-year average of $2.4 billion and a median of $2.1 billion in 2026 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 95.79% in 2022 and plunged 44.17% in 2023, its largest moves.
- Over 5 years, Total Current Liabilities stood at $3.2 billion in 2022, then slumped by 40.35% to $1.9 billion in 2023, then soared by 80.62% to $3.4 billion in 2024, then sank by 36.31% to $2.2 billion in 2025, then dropped by 5.15% to $2.1 billion in 2026.
- The last three Total Current Liabilities figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.49 Bn | 40.29 Bn | 779.09 Mn | 1.29 Bn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 2.06 Bn |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | 1.85 Bn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn | 316.47 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 4.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.76 Mn | 68.66 Mn | - | 16.99 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 7,791.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.06 Bn |
| Mar 31, 2026 | 2.05 Bn |
| Dec 31, 2025 | 2.17 Bn |
| Sep 30, 2025 | 1.81 Bn |
| Jun 30, 2025 | 3.37 Bn |
| Mar 31, 2025 | 3.39 Bn |
| Dec 31, 2024 | 3.41 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.80 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 1.89 Bn |
| Sep 30, 2023 | 1.61 Bn |
| Jun 30, 2023 | 1.77 Bn |
| Mar 31, 2023 | 1.92 Bn |
| Dec 31, 2022 | 3.17 Bn |
| Sep 30, 2022 | 2.88 Bn |
| Jun 30, 2022 | 3.05 Bn |
| Mar 31, 2022 | 3.03 Bn |
| Dec 31, 2021 | 1.80 Bn |
| Sep 30, 2021 | 1.47 Bn |